| | ||||
 |
|
|||
 >4x |
Module 442 |
| General Properties | |
|---|---|
| Below we list the number of gene sets from which the module was composed was originally composed, and the number of genes and experiments that it contains. Clicking on the number of genes will display a detailed list of all the genes in the module. Clicking on the number of experiments will display a detailed list of all the experiments in the module. | |
| Num gene sets: | 2 |
| Num genes: | 8 (see 19 additional genes for this module) |
| Num experiments: | 11 (3 induced, 8 repressed) |
| Gene sets | |
|---|---|
| Below we list the gene sets from which the module was originally composed. Clicking on a gene set will display all the genes associated with that gene set. Also listed are all the other modules in which the gene set participates. | |
| Detweiler01 14 | 442 |
| Perou00 27 | 442 |
| Enriched clinical annotations | ||||
|---|---|---|---|---|
| For each of the clinical annotations, we tested whether it was enriched in the set of experiments in which the module is significantly induced (or repressed). Below we list all such annotations that were enriched in this module with an FDR corrected p-value of 0.05 ('P-value' column), along with the number ('Hits' column) of induced (or repressed) experiments in which they appear. We also show the fraction of experiments with the given annotation that are included in this module ('Hits (%)' column). Rows that correspond to annotations that were enriched in the induced experiments of the module have a red background, while rows corresponding to annotations enriched in the repressed experiments have a green background. For each annotation, we also list the other modules in which it was enriched. | ||||
| Clinical annotation | P-value | Hits | Hits(%) | Modules |
| Blood cancer and cell line | 0.00035 | 7 | 87.5 | 4 5 15 16 17 21 27 31 33 37 46 47 56 57 61 63 64 65 69 70 75 76 79 82 84 85 86 87 94 97 98 99 102 105 114 117 119 120 124 125 126 128 136 138 145 151 158 161 169 170 171 173 174 175 177 178 179 182 188 198 199 201 204 208 214 216 219 233 237 238 241 243 244 245 247 248 250 252 254 255 259 261 265 267 273 277 278 289 291 292 300 301 303 308 312 313 315 316 317 328 329 330 332 340 341 344 345 347 358 361 375 376 378 387 399 403 407 411 433 436 442 451 456 459 466 485 490 491 500 502 512 518 522 525 532 537 539 554 562 568 |
| Enriched GO annotations | ||||
|---|---|---|---|---|
| For each GO annotation, we tested whether it was enriched in the set of genes of the module. Below we list all such annotations that were enriched in this module with an FDR corrected p-value of 0.05 ('P-value' column), along with the number ('Hits' column) of genes in which they appear. We also show the fraction of genes with the given GO annotation that are included in this module ('Hits (%)' column). |
| Visual display | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Below is a visual display of the module. Shown are those arrays in which the module's genes significantly change, and the direction of change (induction/repression) in each array is indicated (middle, labeled 'Module changes'; red/green row). The arrays that correspond to the significant clinical attributes are also shown (top; brown rows). The gene sets that compose the module are also shown (left) along with an indication of the membership of the module genes in these gene sets. | |||||||||
| You can also view the images within GeneXPress by loading the module gxp file file. | |||||||||
|
|||||||||
